Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Laplaud

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Journal of Medical Internet Research|October 1, 2025
Privacy-by-Design Approach to Generate Two Virtual Clinical Trials for Multiple Sclerosis and Release Them as Open Datasets: Evaluation StudyStanislas Demuth, Olivia Rousseau, Igor Faddeenkov, et al.
Respiratory Care|November 28, 2013
Low physical activity is a determinant for elevated blood pressure in high cardiovascular risk obstructive sleep apneaMonique Mendelson, Renaud Tamisier, David Laplaud, et al.
Sleep|November 4, 2014
CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: a randomized, controlled trialMonique Mendelson, Isabelle Vivodtzev, Renaud Tamisier, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2025
Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC studyRyan Ramdani, Julie Pique, Romain Deschamps, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disordersAlexis Montcuquet, Nicolas Collongues, Caroline Papeix, et al.
Brain and Behavior|September 16, 2024
Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohortAmélie Dos Santos, Edouard Courtin, Aurélie Ruet, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes SignatureJérémy Morille, Marion Mandon, Stéphane Rodriguez, et al.
Journal of Neuroinflammation|March 3, 2022
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort studyStanislas Demuth, Maxime Guillaume, Bertrand Bourre, et al.
JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Medical Internet Research|October 1, 2025
Privacy-by-Design Approach to Generate Two Virtual Clinical Trials for Multiple Sclerosis and Release Them as Open Datasets: Evaluation StudyStanislas Demuth, Olivia Rousseau, Igor Faddeenkov, et al.
Respiratory Care|November 28, 2013
Low physical activity is a determinant for elevated blood pressure in high cardiovascular risk obstructive sleep apneaMonique Mendelson, Renaud Tamisier, David Laplaud, et al.
Sleep|November 4, 2014
CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: a randomized, controlled trialMonique Mendelson, Isabelle Vivodtzev, Renaud Tamisier, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2025
Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC studyRyan Ramdani, Julie Pique, Romain Deschamps, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disordersAlexis Montcuquet, Nicolas Collongues, Caroline Papeix, et al.
Brain and Behavior|September 16, 2024
Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohortAmélie Dos Santos, Edouard Courtin, Aurélie Ruet, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes SignatureJérémy Morille, Marion Mandon, Stéphane Rodriguez, et al.
Journal of Neuroinflammation|March 3, 2022
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort studyStanislas Demuth, Maxime Guillaume, Bertrand Bourre, et al.
JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.
Pageof 6